Non-Autoimmune Hemolytic Anemia with Clostridium Ramosum Bacteremia

Tekijä Al-kali, Aref, Oswal, Alok, Tfayli, Arafat
Julkaistu 2008

Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)

Tekijä Al-Kali, Aref, Wierda, William, Keating, Michael, O’Brien, Susan
Julkaistu 2010

The Role of Monoclonal Antibodies in the Management of Leukemia

Tekijä Al-Ameri, Ali, Cherry, Mohamad, Al-Kali, Aref, Ferrajoli, Alessandra
Julkaistu 2010

Competing cell clones in myeloproliferative neoplasm

Tekijä Al-Kali, Aref, Verstovsek, Srdan, Kantarjian, Hagop, Luthra, Rajyalakshmi, Cortes, Jorge
Julkaisussa Blood (2010)

An Erythrocytosis-Associated Mutation in the Zinc Finger of PHD2 Provides Insights into Its Binding of p23

Tekijä Song, Daisheng, Guan, Wei, Coon, Lea M, Al-Kali, Aref, Oliveira, Jennifer L, Lee, Frank S
Julkaisussa Hypoxia (Auckl) (2019)

A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis

Tekijä Shen, Na, Yan, Fei, Pang, Jiuxia, Wu, Lai-Chu, Al-Kali, Aref, Litzow, Mark R., Liu, Shujun
Julkaistu 2014

Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients With FLT3 Mutant Acute Myeloid Leukemia

Tekijä Al-Kali, Aref, Cortes, Jorge, Faderl, Stefan, Jones, Dan, Abril, Caroline, Pierce, Sherry, Brandt, Mark, Kantarjian, Hagop, Ravandi, Farhad
Julkaistu 2011

A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome

Tekijä Almasri, Jehad, Alkhateeb, Hassan B., Firwana, Belal, Sonbol, Mohamad Bassam, Damlaj, Moussab, Wang, Zhen, Murad, M. Hassan, Al-Kali, Aref
Julkaisussa Syst Rev (2018)

A dynamic N(6)-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors

Tekijä Yan, Fei, Al-Kali, Aref, Zhang, Zijie, Liu, Jun, Pang, Jiuxia, Zhao, Na, He, Chuan, Litzow, Mark R., Liu, Shujun
Julkaisussa Cell Res (2018)

Current Event-Free Survival After Sequential Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia

Tekijä Al-Kali, Aref, Kantarjian, Hagop, Shan, Jianqin, Bassett, Roland, Quintás-Cardama, Alfonso, Borthakur, Gautam, Jabbour, Elias, Verstovsek, Srdan, O’Brien, Susan, Cortes, Jorge
Julkaisussa Cancer (2010)

Inactivation of receptor tyrosine kinases reverts aberrant DNA methylation in acute myeloid leukemia

Tekijä Shen, Na, Yan, Fei, Pang, Jiuxia, Zhao, Na, Gangat, Naseema, Wu, Laichu, Bode, Ann M., Al-Kali, Aref, Litzow, Mark R., Liu, Shujun
Julkaisussa Clin Cancer Res (2017)

Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients

Tekijä Al-Kali, Aref, Konoplev, Sergej, Lin, Erpei, Kadia, Tapan, Faderl, Stefan, Ravandi, Farhad, Ayoubi, Mohamad, Brandt, Mark, Cortes, Jorge E., Kantarjian, Hagop, Borthakur, Gautam
Julkaistu 2012

Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis

Tekijä Yang, Xiaojuan, Pang, Jiuxia, Shen, Na, Yan, Fei, Wu, Lai-Chu, Al-Kali, Aref, Litzow, Mark R., Peng, Yong, Lee, Robert J., Liu, Shujun
Julkaisussa Oncotarget (2016)

Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic Hematopathology

Tekijä Osman, Mazen, Akkus, Zeynettin, Jevremovic, Dragan, Nguyen, Phuong L., Roh, Dana, Al-Kali, Aref, Patnaik, Mrinal M., Nanaa, Ahmad, Rizk, Samia, Salama, Mohamed E.
Julkaisussa J Clin Med (2021)

Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal orig...

Tekijä Patnaik, Mrinal M., Lasho, Terra, Howard, Matthew, Finke, Christy, Ketterling, Rhett L., Al-Kali, Aref, Pardanani, Animesh, Droin, Nathalie, Gangat, Naseema, Tefferi, Ayalew, Solary, Eric
Julkaisussa Blood Cancer J (2018)

Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS‐CoV‐2 pandemic

Tekijä Patnaik, Mrinal M., Lasho, Terra, Padron, Eric, McCullough, Kristen, Al‐kali, Aref, Tefferi, Ayalew, Zeidan, Amer M., Gangat, Naseema, Savona, Michael, Steensma, David P., Solary, Eric
Julkaisussa Am J Hematol (2020)

One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience

Tekijä Tefferi, Ayalew, Lasho, Terra L., Jimma, Thitina, Finke, Christy M., Gangat, Naseema, Vaidya, Rakhee, Begna, Kebede H., Al-Kali, Aref, Ketterling, Rhett P., Hanson, Curtis A., Pardanani, Animesh
Julkaistu 2012

The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia

Tekijä Tibes, Raoul, Al-Kali, Aref, Oliver, Gavin R, Delman, Devora H, Hansen, Nanna, Bhagavatula, Keerthi, Mohan, Jayaram, Rakhshan, Fariborz, Wood, Thomas, Foran, James M., Mesa, Ruben A., Bogenberger, James M.
Julkaisussa J Hematol Oncol (2015)

Histone deacetylase inhibitors reduce differentiating osteoblast-mediated protection of acute myeloid leukemia cells from cytarabine

Tekijä Sterner, Rosalie M., Kremer, Kimberly N., Al-Kali, Aref, Patnaik, Mrinal M., Gangat, Naseema, Litzow, Mark R., Kaufmann, Scott H., Westendorf, Jennifer J., van Wijnen, Andre J., Hedin, Karen E.
Julkaisussa Oncotarget (2017)

Momelotinib therapy for myelofibrosis: a 7-year follow-up

Tekijä Tefferi, Ayalew, Barraco, Daniela, Lasho, Terra L., Shah, Sahrish, Begna, Kebede H., Al-Kali, Aref, Hogan, William J., Litzow, Mark R., Hanson, Curtis A., Ketterling, Rhett P., Gangat, Naseema, Pardanani, Animesh
Julkaisussa Blood Cancer J (2018)